603998 方盛制药
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)4.69513.11922.1065.9675.600
总资产报酬率 ROA (%)2.2166.22410.1602.8313.011
投入资产回报率 ROIC (%)2.9238.28614.4124.0573.831

边际利润分析
销售毛利率 (%)73.18668.09867.28364.05463.738
营业利润率 (%)18.02312.06318.5296.3625.660
息税前利润/营业总收入 (%)18.77713.15019.3366.9216.465
净利润/营业总收入 (%)15.57311.03015.4414.4624.205

收益指标分析
经营活动净收益/利润总额(%)78.91375.81044.270119.633128.593
价值变动净收益/利润总额(%)3.117-1.87050.887-10.422-27.158
营业外收支净额/利润总额(%)-0.0183.390-1.673-9.806-4.934

偿债能力分析
流动比率 (X)0.8510.7381.1920.6900.908
速动比率 (X)0.5530.4750.8880.4860.668
资产负债率 (%)49.03448.43448.40151.79743.564
带息债务/全部投入资本 (%)34.06733.87730.42327.052--
股东权益/带息债务 (%)182.782183.662210.940245.510270.844
股东权益/负债合计 (%)96.00797.71098.27985.381117.880
利息保障倍数 (X)24.80219.79617.3866.1436.034

营运能力分析
应收账款周转天数 (天)48.16142.79142.26748.9570.000
存货周转天数 (天)265.335218.853171.968149.0760.000